Breaking News, Collaborations & Alliances

NJ Bio Inc. and Charles River Partner to Offer ADC Services

Alliance aims to advance ADC development and manufacturing services.

Author Image

By: Charlie Sternberg

Associate Editor

NJ Bio Inc. and Charles River Laboratories Inc. have entered a strategic alliance to offer complementary services to clients including early development and optimization to manufacturing of antibody-drug conjugates (ADCs).   The partnership aims to offer seamless complementary services to enhance outcomes and accelerate time-to-market for ADCs. Additionally, this alliance enables Charles River to innovate with engineered antibodies, while NJ Bio focuses on synthesizing and manufacturing ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters